# Anlon Healthcare Ltd (AHCL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹13.91
Day Change: +0.14%
52W High: ₹17.27
52W Low: ₹9.08
Market Cap: ₹716 Cr

## Valuation
P/E: 20.72
P/B: 2.64
EPS: ₹0.65
Book Value: ₹5.11
Dividend Yield: 0%

## Returns
1Y Return: -5.59%

## Profitability
ROE: 0%
ROCE: 24.21%
Debt/Equity: 0.27
Revenue Growth: 280.1%
Profit Growth: 0%
EBITDA Margin: 29.22%
Operating Margin: 33.7%

## About
Anlon Healthcare Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Anlon Healthcare Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- Announcement: Updates On Acquisition
- BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.754Z
Price History Updated: 2026-05-17T21:23:55.359Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:23:55.359Z
Quant Updated: 2026-05-17T21:23:55.359Z
Sentiment Updated: 2026-05-17T21:23:55.359Z
Financials Status: current
Financials Updated: 2026-05-19T13:30:06.853Z
Financials Last Attempt: 2026-05-19T13:30:06.853Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹120.29 Cr
Operating Profit: ₹30.9 Cr (OPM 25.69%)
Net Profit: ₹20.52 Cr
Tax: ₹6.37 Cr

## Annual P&L History
FY25: Rev ₹120.29Cr | PAT ₹20.52Cr | OPM 25.69%
FY24: Rev ₹66.58Cr | PAT ₹9.66Cr | OPM 20.79%
FY23: Rev ₹112.88Cr | PAT ₹5.82Cr | OPM 9.8%

## Balance Sheet (FY25)
Total Assets: ₹181.3 Cr
Total Liabilities: ₹100.88 Cr
Borrowings: ₹66.55 Cr
Cash: ₹1.45 Cr

## Shareholding
undefined: undefined%
undefined: undefined%

## Board
- Punitkumar Rameshbhai Rasadia, Chairman & MD
- Amitabhen Chhaganbhai Pragada, Company Secretary & Compliance Officer
- Meet Atulkumar Vachhani, Whole-Time Executive Director
- Naimish Dilipbhai Bhatt, Chief Financial Officer
- Chetanbhai Girdharbhai Raiyani, Head of Quality & RA

---
Source: rupiya.io/stocks/ahcl
Disclaimer: For research and education only. Not investment advice.